Microplate instrumentation market seen reaching $10.43 billion by 2030

The microplate instrumentation and supplies market is projected to rise from $7.43 billion in 2025 to $7.95 billion in 2026, with growth tied to pharmaceutical research, diagnostics and lab automation. The Business Research Company says North America led the market in 2025 and expects demand for personalized medicine and high-throughput testing to keep expanding the category through 2030.

Why it matters: - Microplate instrumentation and supplies support high-throughput testing, diagnostic workflows and research experiments that depend on fast, repeatable sample analysis. - The market’s projected rise signals continued spending across pharmaceutical research, laboratory automation and life sciences infrastructure. - Growth in personalized medicine adds demand for tools that can analyze biological samples at scale and help tailor treatments to individual patients.

What happened: - The Business Research Company projected the microplate instrumentation and supplies market will grow from $7.43 billion in 2025 to $7.95 billion in 2026. - The forecast implies 7.1% CAGR growth in 2026. - The market is expected to reach $10.43 billion by 2030, with a 7.0% CAGR over the forecast period. - North America held the largest share of the global market in 2025.

The details: - The report links near-term growth to pharmaceutical research, wider adoption of microplate-based assays, expansion of diagnostic labs, rising demand for efficient sample analysis and advances in academic and life sciences research. - Longer-term growth is tied to drug discovery pipelines, high-throughput diagnostics, laboratory automation, biotechnology startups and the need for reproducible and scalable testing solutions. - The report points to wider adoption of high-throughput screening platforms, rising demand for multimode microplate readers, more automation in lab workflows, stronger diagnostic and research lab infrastructure, and greater use of disposable microplates and accessories. - Microplate instrumentation and supplies include tools and consumables used with microplates, which are flat plates with multiple wells that act as miniature test tubes. - The products are used for high-throughput screening, diagnostic testing and other research experiments. - The company said the category enables simultaneous, precise and reproducible processing of numerous samples. - The report’s regional coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report package also includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - A free sample and the full report are available as inline links: free sample and full report.

Between the lines: - Personalized medicine is a major demand driver because it relies on accurate, high-throughput analysis of genetic and cellular profiles. - The report cites Personalized Medicine Coalition data showing the FDA approved 16 new personalized treatments for rare diseases in 2023, up from 6 in 2022. - That same update included seven cancer drugs and three treatments for other conditions, underscoring broader momentum in tailored therapies. - North America’s lead suggests the market is already concentrated in regions with dense research, diagnostic and pharmaceutical activity.

What's next: - The market is expected to keep expanding as drug discovery pipelines deepen and labs invest more in automation and reproducible testing. - Demand should also rise as diagnostic and research organizations scale infrastructure and adopt more high-throughput tools. - Growth in biotechnology startups and personalized medicine should continue to support microplate-related spending through 2030.

The bottom line: - Microplate instrumentation and supplies are moving from a niche lab category to a core enabling market for diagnostics, drug discovery and personalized medicine.